摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-amino-11,12-dihydro-11-(2,3,4-trimethoxyphenyl)benzo[c]phenanthridine | 420834-63-5

中文名称
——
中文别名
——
英文名称
6-amino-11,12-dihydro-11-(2,3,4-trimethoxyphenyl)benzo[c]phenanthridine
英文别名
11-(2,3,4-Trimethoxyphenyl)-11,12-dihydrobenzo[c]phenanthridin-6-amine
6-amino-11,12-dihydro-11-(2,3,4-trimethoxyphenyl)benzo[c]phenanthridine化学式
CAS
420834-63-5
化学式
C26H24N2O3
mdl
——
分子量
412.488
InChiKey
HRSAZIXAEDARCK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.1
  • 重原子数:
    31
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    66.6
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    6-amino-11,12-dihydro-11-(2,3,4-trimethoxyphenyl)benzo[c]phenanthridine2,3-二氯-5,6-二氰基-1,4-苯醌 作用下, 以 1,4-二氧六环 为溶剂, 反应 12.0h, 生成 11-(2,3,4-Trimethoxyphenyl)benzo[c]phenanthridin-6-amine
    参考文献:
    名称:
    Synthesis and Biological Evaluation of 11-Substituted 6-Aminobenzo[c]phenanthridine Derivatives, a New Class of Antitumor Agents
    摘要:
    The synthesis of 11-substituted 6-amino-11,12-dihydrobenzo[c]phenanthridines and 11-substituted 6-aminobenzo[c]phenanthridines through an efficient method is described. The antiproliferative activity of selected compounds against a wide panel of tumor cell lines was tested in the in vitro anticancer screening and the in vivo hollow fiber assay of the National Cancer Institute. Several compounds turned out to exhibit considerable cytotoxicity for tumor cells. For the study of structure-activity relationships different substituents were introduced in the 11-position. Compounds with methoxyphenyl substituents tended to show the highest potency. Several compounds exhibited noteworthy antitumor activity with GI(50) values across all cell lines < 1 mu M. 6-Amino-11-(3,4,5-trimethoxyphenyl)benzo [c] phenanthridine perchlorate was the most potent agent in the NCI's in vivo hollow fiber assay. Most of the tested compounds showed a remarkable selectivity for leukemia, breast cancer, and prostate cancer.
    DOI:
    10.1021/jm0490888
  • 作为产物:
    参考文献:
    名称:
    Synthesis and Biological Evaluation of 11-Substituted 6-Aminobenzo[c]phenanthridine Derivatives, a New Class of Antitumor Agents
    摘要:
    The synthesis of 11-substituted 6-amino-11,12-dihydrobenzo[c]phenanthridines and 11-substituted 6-aminobenzo[c]phenanthridines through an efficient method is described. The antiproliferative activity of selected compounds against a wide panel of tumor cell lines was tested in the in vitro anticancer screening and the in vivo hollow fiber assay of the National Cancer Institute. Several compounds turned out to exhibit considerable cytotoxicity for tumor cells. For the study of structure-activity relationships different substituents were introduced in the 11-position. Compounds with methoxyphenyl substituents tended to show the highest potency. Several compounds exhibited noteworthy antitumor activity with GI(50) values across all cell lines < 1 mu M. 6-Amino-11-(3,4,5-trimethoxyphenyl)benzo [c] phenanthridine perchlorate was the most potent agent in the NCI's in vivo hollow fiber assay. Most of the tested compounds showed a remarkable selectivity for leukemia, breast cancer, and prostate cancer.
    DOI:
    10.1021/jm0490888
点击查看最新优质反应信息

文献信息

  • PHENANTHRIDINE DERIVATIVES AND ANTITUMORAL MEDICAMENTS CONTAINING PHENANTHRIDINE
    申请人:——
    公开号:US20040034051A1
    公开(公告)日:2004-02-19
    The invention relates to novel phenanthridine derivatives and to medicaments, which are for use in antitumoral therapy and prophylaxis and which contain these phenanthridine derivatives. It could be shown that up to now specifically substituted phenanthridine derivatives of the prior art neither have a known nor an antitumoral activity that is to be expected.
    本发明涉及新型菲啶生物以及用于抗肿瘤治疗和预防并含有这些菲啶生物的药物。迄今为止,现有技术中的特异性取代菲啶生物既不具有已知的抗肿瘤活性,也不具有预期的抗肿瘤活性。
  • PHENANTHRIDINDERIVATE UND PHENANTHRIDIN ENTHALTENDE ANTITUMORALE ARZNEIMITTEL
    申请人:Clement, Bernd
    公开号:EP1334115B1
    公开(公告)日:2007-05-16
  • US6747038B2
    申请人:——
    公开号:US6747038B2
    公开(公告)日:2004-06-08
查看更多